Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients

Clinical Nephrology

Volumn 66, Issue 6, 2006, Pages 433-439

  Weinreich, T ^a   De los Rios T ^b   Gauly, A ^b   Passlick Deetjen, J ^b,c  

^a Nephrologisches Zentrum Villingen Schwenningen   (Germany)

^b FRESENIUS MEDICAL CARE   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cardiovascular risk; End stage renal disease (ESRD); Hypertension; Intensified hemodialysis; Left ventricular mass index (LVMI)

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; PHOSPHATE;

ADULT; AGED; AMBULATORY MONITORING; ANEMIA; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DRY WEIGHT; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; LONG TERM CARE; MALE; OBSERVATIONAL STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 33845443333     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp66433     Document Type: Article

References (23)

1. Al-Hejaili F, Kortas C, Leitch R et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol. 2003; 14: 2322-2328.
2. Canella G, Paoletti E, Traverso GB, Delfino R et al. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis. 1997; 30: 659-664.
3. Chan C, Floras JS, Miller JA et al. Improvement in ejection fraction by nocturnal hemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant. 2002; 17: 1518-1521.
4. Chan CT, Floras JS, Richardson RMA, Pierratos A, Miller JA et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002; 61: 2235-2239.
5. Charra B, Chazot C, Jean G et al. Long 3- × 8-hr dialysis: a three-decade summary. J Nephrol. 2003; 16 (Suppl 7): S64-S69.
6. Deveraux RB, Reicheck N. Echocardiographic determination of left ventricular mass in men: anatomic validation of the method. Circulation. 1977; 55: 613-618.
7. Dyadyk AI, Bagriy AE, Lebed IA et al. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure. Nephrol Dial Transplant. 1997; 12: 945-951.
8. Fagiuli RM, Reboldi G, Quintiliani G et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001; 38: 371-376.
9. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186-192.
10. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32 (5 Suppl 3): 112-119.
11. Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant. 1998; 12: 10-14.
12. Harnett JD, Kent GM, Barre PE et al. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol. 1994; 4: 1486-1490.
13. Kooistra MP, Vos J, Koomans HA et al. Daily home hemodialysis in The Netherlands: effects on metabolic control, hemodynamics and quality of life. Nephrol Dial Transplant. 1998; 13: 2853-2860.
14. Luik MJ, v.d. Sande FM, Weidemann P et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients: a prospective study. Am J Nephrol. 2001; 21: 471-478.
15. Musci I, Hercz G, Uldall R, et al. Control of phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998; 53: 1399-1404.
16. NKF-K/DOQI. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42 (4 Suppl 3): 1-201.
17. Pierratos A, McFarlane P, Chan CT. Quotidian dialysis - update. Curr Opin Nephrol Hypertens. 2005; 14: 119-124.
18. Rao M, Muirhead N, Klarenbach S et al. Management of anemia with quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl 1): S18-S23.
19. Sahn DY, DeMaria A, Kissio J et al. Recommendation concerning quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 1072-1083.
20. 2-microglobulin. Int J Art of Organs. 2002; 25: 411-420.
21. Ting GO, Kjellstrand C, Freitas T et al. Long-term study of high comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003; 42: 1020-1035.
22. Twardowski AJ. Daily dialysis: is this a reasonable option for the new millennium? Nephrol Dial Transplant. 2001; 16: 1321-1324.
23. Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol. 2004; 15 (Suppl 1): S77-S80.